Literature DB >> 27216701

MicroRNA Control of p53.

Juan Liu1, Cen Zhang1, Yuhan Zhao1, Zhaohui Feng1.   

Abstract

Tumor suppressor p53 plays a central role in tumor suppression. As a transcription factor, p53 mainly exerts its tumor suppressive function through transcriptional regulation of many target genes. To maintain the proper function of p53, p53 protein level and activity are exquisitely controlled by a group of positive and negative regulators in cells. Thus, p53, its regulators, and regulated genes form a complicated p53 signaling network. microRNAs (miRNAs) are a group of endogenous small non-coding RNA molecules. miRNAs play an important role in regulation of gene expression by blocking translational protein synthesis and/or degrading target mRNAs. Recent studies have demonstrated that p53 and its network are regulated by miRNAs at multiple levels. Some miRNAs regulate the level and function of p53 through directly targeting p53, whereas some other miRNAs target regulators of p53, such as MDM2 and MDM4, to indirectly regulate the activity and function of p53. On the other hand, p53 also regulates the transcriptional expression and the biogenesis of a group of miRNAs, which contributes to the tumor suppressive function of p53. p53 is the most frequently mutated gene in human cancer. Many tumor-associated mutant p53, which have "gain-of-function" activities in tumorigenesis independently of wild type p53, can regulate the expression of different miRNAs and modulate the biogenesis of specific miRNAs to promote tumorigenesis. These findings have demonstrated that miRNAs are important regulators and mediators of p53 and its signaling pathway, which highlights a pivotal role of miRNAs in the p53 network and cancer. J. Cell. Biochem. 118: 7-14, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CANCER; MDM2; microRNA; p53

Mesh:

Substances:

Year:  2016        PMID: 27216701     DOI: 10.1002/jcb.25609

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  54 in total

1.  MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis.

Authors:  Anand Singh; Nisan Bhattacharyya; Abhishek Srivastava; Nathanael Pruett; R Taylor Ripley; David S Schrump; Chuong D Hoang
Journal:  Mol Ther       Date:  2019-06-04       Impact factor: 11.454

Review 2.  Ceramide Signaling and p53 Pathways.

Authors:  Kristen A Jeffries; Natalia I Krupenko
Journal:  Adv Cancer Res       Date:  2018-06-01       Impact factor: 6.242

Review 3.  The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

4.  The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs.

Authors:  Martha L Slattery; Lila E Mullany; Roger K Wolff; Lori C Sakoda; Wade S Samowitz; Jennifer S Herrick
Journal:  Genomics       Date:  2018-06-01       Impact factor: 5.736

5.  Integrated analysis of miRNA and mRNA expression profiles in p53-edited PFF cells.

Authors:  Chuanmin Qiao; Weiwei Liu; Haoyun Jiang; Maozhang He; Qiang Yang; Yuyun Xing
Journal:  Cell Cycle       Date:  2020-03-26       Impact factor: 4.534

6.  The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.

Authors:  Siddharth Shukla; Glen A Bjerke; Denise Muhlrad; Rui Yi; Roy Parker
Journal:  Mol Cell       Date:  2019-02-12       Impact factor: 17.970

Review 7.  The emerging role of leukemia inhibitory factor in cancer and therapy.

Authors:  Cen Zhang; Juan Liu; Jianming Wang; Wenwei Hu; Zhaohui Feng
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

Review 8.  Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy.

Authors:  Yong Liu; Patrick L Leslie; Yanping Zhang
Journal:  Trends Cancer       Date:  2020-11-13

Review 9.  MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells.

Authors:  Matthew L Potter; William D Hill; Carlos M Isales; Mark W Hamrick; Sadanand Fulzele
Journal:  Bone       Date:  2020-10-03       Impact factor: 4.398

10.  Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma.

Authors:  Shu-Hsuan Liu; Kai-Wen Hsu; Yo-Liang Lai; Yu-Feng Lin; Fang-Hsin Chen; Pei-Hwa Peng; Li-Jie Lin; Heng-Hsiung Wu; Chia-Yang Li; Shu-Chi Wang; Min-Zu Wu; Yuh-Pyng Sher; Wei-Chung Cheng
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.